QL
NVCR icon

Quarry LP’s NovoCure NVCR Stock Holding History

Quarry LP’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41K Buy
+225
New +$3.4K ﹤0.01% 1298
2026
Q1 		– Sell
-2,313
Closed -$29.9K – 2011
2025
Q4 		$29.9K Buy
2,313
+826
+56% +$10.6K ﹤0.01% 827
2025
Q3 		$19.2K Sell
1,487
-1,413
-49% -$18.9K ﹤0.01% 1435
2025
Q2 		$51.6K Buy
+2,900
New +$50.5K 0.01% 839
2025
Q1 		– Sell
-1,346
Closed -$40.1K – 1908
2024
Q4 		$40.1K Sell
1,346
-215
-14% -$4.55K 0.01% 877
2024
Q3 		$24.4K Buy
1,561
+389
+33% +$7.05K 0.01% 1045
2024
Q2 		$20.1K Sell
1,172
-808
-41% -$14.2K 0.01% 1093
2024
Q1 		$30.9K Buy
1,980
+778
+65% +$11.4K 0.01% 706
2023
Q4 		$17.9K Buy
+1,202
New +$16.1K ﹤0.01% 808

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Quarry LP's NVCR Position: Q2 2026 in Review

Quarry LP opened a new position in NovoCure (NVCR) in Q2 2026: 225 shares worth $3.41K. The stake represents ﹤0.01% of the portfolio and ranks #1298 among its holdings. This is a return to the name: Quarry LP previously reported a position in NVCR as recently as Q4 2025.

Quarry LP first reported a position in NVCR in Q4 2023 and has held it in 9 quarters since. The position peaked at $51.6K in Q2 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Quarry LP held 225 shares of NovoCure worth $3.41K as of Q2 2026.
  • NovoCure was a new Quarry LP position in Q2 2026.
  • NovoCure made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1298 holding.
  • Quarry LP first reported a position in NovoCure in Q4 2023 and has held it in 9 quarters since.
  • Quarry LP's NovoCure position peaked at $51.6K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.